Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor

By Kallio E.   Koskinen P.   Buchdunger E.   Lemstrom K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 187-187

Elsevier

Access to resources Recommend Favorite

Potentiation of Mitogenic Activity of Platelet-Derived Growth Factor by Physiological Concentrations of Insulin via the MAP Kinase Cascade in Rat A10 Vascular Smooth Muscle Cells

By YAMADA H.  

International Journal of Experimental Diabetes Research, Vol. 3, Iss. 2, 2002-01 ,pp. : 131-144

Informa Healthcare

Access to resources Recommend Favorite

Expression of Platelet-Derived Growth Factor in the Development of Cardiac Allograft Vasculopathy in the Rat

By Lemstrom K.   Sihvola R.   Koskinen P.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1045-1046

Elsevier

Access to resources Recommend Favorite

The role of the beta chemokines in experimental obliterative bronchiolitis

By Farivar A.S.   Krishnadasan B.   Naidu B.V.   Woolley S.M.   Mulligan M.S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 3, 2003-12 ,pp. : 210-216

Elsevier

Access to resources Recommend Favorite

Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation

By Rigatto C.   Rush D.   Perry Y.   Walker S.   Bose R.   Bolli P.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2591-2592

Elsevier

Access to resources Recommend Favorite